Theleme Partners LLP Invests $91.14 Million in Equifax, Inc. $EFX

Theleme Partners LLP bought a new stake in Equifax, Inc. (NYSE:EFX) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 574,213 shares of the credit services provider’s stock, valued at approximately $91,139,000. Equifax makes up 5.4% of Theleme Partners LLP’s investment portfolio, making the stock its 7th biggest position. Theleme Partners LLP owned approximately 0.49% of Equifax as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of EFX. Pictet Asset Management Holding SA raised its stake in Equifax by 52.6% during the fourth quarter. Pictet Asset Management Holding SA now owns 650,391 shares of the credit services provider’s stock valued at $141,199,000 after buying an additional 224,073 shares in the last quarter. Brighton Jones LLC increased its holdings in shares of Equifax by 49.2% in the 4th quarter. Brighton Jones LLC now owns 3,638 shares of the credit services provider’s stock valued at $927,000 after acquiring an additional 1,200 shares during the last quarter. Canada Post Corp Registered Pension Plan raised its position in shares of Equifax by 1,253.8% during the 4th quarter. Canada Post Corp Registered Pension Plan now owns 24,978 shares of the credit services provider’s stock valued at $5,420,000 after acquiring an additional 23,133 shares in the last quarter. Louisiana State Employees Retirement System acquired a new stake in shares of Equifax during the 1st quarter valued at approximately $1,098,000. Finally, Oppenheimer Asset Management Inc. lifted its stake in Equifax by 39.9% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 34,056 shares of the credit services provider’s stock worth $7,389,000 after purchasing an additional 9,710 shares during the last quarter. 96.20% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have weighed in on EFX shares. Morgan Stanley lowered their target price on shares of Equifax from $243.00 to $225.00 and set an “overweight” rating for the company in a research note on Wednesday, July 22nd. BMO Capital Markets lowered their price objective on shares of Equifax from $195.00 to $179.00 and set a “market perform” rating for the company in a research report on Monday, July 13th. Deutsche Bank Aktiengesellschaft set a $208.00 price objective on shares of Equifax in a research note on Wednesday, July 22nd. UBS Group reissued a “buy” rating and issued a $220.00 target price on shares of Equifax in a report on Wednesday, July 8th. Finally, Robert W. Baird reduced their price target on shares of Equifax from $245.00 to $232.00 and set an “outperform” rating for the company in a report on Wednesday, July 22nd. Fourteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $216.89.

Equifax Stock Performance

Shares of EFX stock opened at $192.98 on Monday. Equifax, Inc. has a 12-month low of $150.74 and a 12-month high of $271.84. The firm has a market capitalization of $22.67 billion, a price-to-earnings ratio of 33.92, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30. The business has a 50 day simple moving average of $172.16 and a 200 day simple moving average of $177.97. The company has a debt-to-equity ratio of 0.92, a current ratio of 0.60 and a quick ratio of 0.60.

Equifax (NYSE:EFX) last announced its earnings results on Tuesday, July 21st. The credit services provider reported $2.25 earnings per share for the quarter, beating the consensus estimate of $2.20 by $0.05. Equifax had a return on equity of 21.61% and a net margin of 10.73%.The firm had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.70 billion. During the same quarter in the previous year, the business earned $2.00 EPS. The firm’s revenue for the quarter was up 10.6% on a year-over-year basis. Equifax has set its Q3 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.390-8.690 EPS. On average, equities research analysts anticipate that Equifax, Inc. will post 8.57 EPS for the current year.

Equifax Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Monday, August 31st will be paid a dividend of $0.56 per share. The ex-dividend date of this dividend is Monday, August 31st. This represents a $2.24 annualized dividend and a yield of 1.2%. Equifax’s dividend payout ratio (DPR) is presently 39.37%.

Insider Buying and Selling at Equifax

In other news, CEO Mark W. Begor sold 37,791 shares of the company’s stock in a transaction that occurred on Friday, July 24th. The shares were sold at an average price of $172.16, for a total value of $6,506,098.56. Following the completion of the sale, the chief executive officer directly owned 271,890 shares of the company’s stock, valued at approximately $46,808,582.40. This represents a 12.20% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.70% of the company’s stock.

Equifax Profile

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.